Encontrado 1 documento, a visualizar página 1 de 1

Ordenado por Data

Improving the identification of high-risk non-metastatic castration-resistant p...

Rosinha, Alina; Rabaça, Carlos; Calais, Fernando; Pinto, João Moreira; Barreira, João Vasco; Fernandes, Ricardo; Ramos, Rodrigo; Fialho, Ana Cristina

Non-metastatic castration-resistant prostate cancer (nmCRPC) represents a challenging disease state in prostate cancer care. nmCRPC patients with a high risk of progression to metastatic disease who are identified by a prostate-specific antigen doubling time (PSADT) ≤10 months are eligible for treatment with the novel androgen receptor inhibitors (ARIs), shown to delay disease progression and extend survival. H...


1 Resultados

Texto Pesquisado

Refinar resultados

Autor










Data


Tipo de Documento


Tipo de acesso


Recurso


Assunto